Overview

Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES: Determine the efficacy of midodrine, a selective alpha 1 adrenergic agonist, in preventing neurally mediated syncope.
Phase:
N/A
Details
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Treatments:
Adrenergic Agonists
Midodrine